fbpx

DeepIntent Survey Reveals That Pharmaceutical Advertising Motivates Patients to Research Treatment and Medication Options

DeepIntent surveyed 1,244 U.S. patients in August 2021 about their attitudes toward pharmaceutical ads and whether they find them relevant.

In this article, Pharmaceutical Executive Magazine shares key takeaways from the survey revealing how advertising motivates patients to research their treatment and medication options. DeepIntent’s CEO Chris Paquette also shares the opportunities healthcare marketers can act on as a result of this research.

Read more here.

More News

Article
Pharma marketing 2022: More digital shifts for reps, ads and drug launches, plus reputation and the metaverse
What trends can healthcare marketers expect in 2022? In this article for Endpoints News, CEO Chris Paquette discusses how pharma brands will be increasing...
Read More
Article
Improving Patient Outcomes with Machine Learning
Artificial intelligence and machine learning technology are revolutionizing the healthcare industry right before our very eyes. In this article for AiThority.com, CEO Chris Paquette...
Read More
Article
Is that drug ad for me? People pay more attention to pharma DTC for familiar conditions, study finds
When pharma ads are relevant, they drive patient action. In this article, Endpoints News highlights the findings from DeepIntent's research study on patient attitudes...
Read More